HK Stock MarketDetailed Quotes

03347 TIGERMED

Watchlist
  • 53.000
  • +5.300+11.11%
Not Open Oct 4 16:08 CST
45.84BMarket Cap36.99P/E (TTM)

TIGERMED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
-9.50%3.36B
-8.00%1.66B
4.21%7.38B
4.52%5.65B
3.25%3.71B
-0.73%1.8B
35.91%7.09B
59.23%5.41B
74.78%3.59B
101.55%1.82B
Operating income
-9.50%3.36B
-8.00%1.66B
4.21%7.38B
4.52%5.65B
3.25%3.71B
-0.73%1.8B
35.91%7.09B
59.23%5.41B
74.78%3.59B
101.55%1.82B
Cost of sales
----
----
-6.12%-4.56B
----
----
----
-45.01%-4.3B
----
-99.72%-2.18B
----
Operating expenses
9.17%-2.03B
5.23%-1.03B
-6.12%-4.56B
-4.12%-3.37B
-2.48%-2.23B
2.06%-1.09B
-45.01%-4.3B
-79.13%-3.24B
-99.72%-2.18B
-132.28%-1.11B
Gross profit
-10.00%1.33B
-12.21%628.12M
1.26%2.82B
5.12%2.28B
4.42%1.48B
1.37%715.52M
23.90%2.79B
36.58%2.17B
46.69%1.42B
66.79%705.85M
Selling expenses
-13.91%-101.38M
-3.43%-46.45M
-24.97%-187.32M
-22.94%-132.7M
-11.19%-89M
-16.61%-44.91M
-15.84%-149.89M
-12.61%-107.94M
-20.08%-80.04M
-21.74%-38.51M
Administrative expenses
-8.70%-376.62M
-3.60%-177.07M
-3.01%-662.7M
-14.39%-527.54M
-7.81%-346.47M
-7.54%-170.92M
-15.95%-643.32M
-18.67%-461.2M
-30.28%-321.38M
-39.22%-158.95M
Research and development expenses
2.65%-124.69M
0.95%-63.91M
-11.48%-261.56M
-14.20%-195.34M
-15.89%-128.08M
-13.22%-64.52M
-10.76%-234.62M
-10.50%-171.06M
-18.80%-110.52M
-21.33%-56.99M
Profit from asset sales
25,346.07%1.49M
32,651.46%1.15M
----
282.55%45.22K
---5.9K
41.47%-3.54K
----
95.63%-24.77K
----
-20.24%-6.05K
Revaluation surplus
-118.58%-98.4M
-92.77%12.75M
----
76.46%710.39M
--529.76M
40.98%176.41M
----
-63.97%402.59M
----
-71.44%125.13M
-Changes in the fair value of other assets
-118.58%-98.4M
-92.77%12.75M
----
76.46%710.39M
--529.76M
40.98%176.41M
----
-63.97%402.59M
----
-71.44%125.13M
Impairment and provision
-21.18%-36.08M
11.22%-18.4M
-177.10%-68.1M
-0.74%-45.34M
-4.81%-29.78M
-76.90%-20.73M
-0.61%-24.58M
-152.89%-45.01M
-177.13%-28.41M
-105.74%-11.72M
-Other impairment is provision
-21.18%-36.08M
11.22%-18.4M
-177.10%-68.1M
-0.74%-45.34M
-4.81%-29.78M
-76.90%-20.73M
-0.61%-24.58M
-152.89%-45.01M
-177.13%-28.41M
-105.74%-11.72M
Special items of operating profit
-18.28%88.09M
-61.93%11.78M
-4.57%863.91M
25.78%138.34M
-81.95%107.8M
-50.70%30.94M
-61.84%905.28M
-17.65%109.98M
-48.26%597.37M
79.40%62.75M
Operating profit
-55.58%670.96M
-44.66%340.28M
-5.06%2.5B
17.21%2.21B
2.38%1.51B
-1.46%614.94M
-28.70%2.64B
-13.08%1.88B
-13.47%1.48B
-10.08%624.06M
Financing cost
-81.71%16.11M
37.34%21.92M
-44.14%-119.9M
-11.06%105.76M
383.86%88.09M
-47.37%15.96M
-233.92%-83.18M
-32.28%118.91M
-290.77%-31.04M
-51.30%30.32M
Share of profits of associates
----
----
164.52%105.18M
----
----
----
177.13%39.76M
----
4,817.84%35.56M
----
Special items of earning before tax
452.48%3.02M
2.21%167.98K
----
-45.03%2.75M
--547.3K
-89.86%164.35K
----
201.12%4.99M
----
87.04%1.62M
Earning before tax
-56.85%690.09M
-42.58%362.36M
-4.04%2.49B
15.38%2.31B
8.06%1.6B
-3.80%631.06M
-29.67%2.59B
-14.12%2.01B
-12.83%1.48B
-13.36%656M
Tax
30.64%-132.51M
20.63%-49.79M
-7.96%-338.61M
-22.61%-286.62M
-17.76%-191.06M
23.52%-62.74M
-7.10%-313.65M
-55.66%-233.77M
-56.70%-162.24M
-137.02%-82.03M
After-tax profit from continuing operations
-60.40%557.58M
-45.00%312.57M
-5.68%2.15B
14.42%2.03B
6.87%1.41B
-0.98%568.33M
-32.84%2.28B
-18.92%1.77B
-17.35%1.32B
-20.56%573.97M
Earning after tax
-60.40%557.58M
-45.00%312.57M
-5.68%2.15B
14.42%2.03B
6.87%1.41B
-0.98%568.33M
-32.84%2.28B
-18.92%1.77B
-17.35%1.32B
-20.56%573.97M
Minority profit
227.70%64.73M
59,975.46%77.5M
-52.83%125.08M
-11.54%148.24M
-84.28%19.75M
-100.23%-129.43K
-48.76%265.17M
-58.59%167.58M
-62.42%125.62M
-79.20%55.55M
Profit attributable to shareholders
-64.50%492.85M
-58.65%235.07M
0.52%2.03B
17.13%1.88B
16.47%1.39B
9.65%568.46M
-29.98%2.02B
-9.90%1.6B
-5.39%1.19B
13.82%518.42M
Basic earnings per share
-64.60%0.57
-59.09%0.27
0.43%2.34
16.67%2.17
16.67%1.61
10.00%0.66
-29.82%2.33
-9.27%1.86
-4.83%1.38
15.38%0.6
Diluted earnings per share
-64.60%0.57
-59.09%0.27
0.43%2.34
16.67%2.17
16.67%1.61
10.00%0.66
-29.61%2.33
-8.82%1.86
-4.17%1.38
15.38%0.6
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
IAS
CAS (2007)
CAS (2007)
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited
--
--
--
Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover -9.50%3.36B-8.00%1.66B4.21%7.38B4.52%5.65B3.25%3.71B-0.73%1.8B35.91%7.09B59.23%5.41B74.78%3.59B101.55%1.82B
Operating income -9.50%3.36B-8.00%1.66B4.21%7.38B4.52%5.65B3.25%3.71B-0.73%1.8B35.91%7.09B59.23%5.41B74.78%3.59B101.55%1.82B
Cost of sales ---------6.12%-4.56B-------------45.01%-4.3B-----99.72%-2.18B----
Operating expenses 9.17%-2.03B5.23%-1.03B-6.12%-4.56B-4.12%-3.37B-2.48%-2.23B2.06%-1.09B-45.01%-4.3B-79.13%-3.24B-99.72%-2.18B-132.28%-1.11B
Gross profit -10.00%1.33B-12.21%628.12M1.26%2.82B5.12%2.28B4.42%1.48B1.37%715.52M23.90%2.79B36.58%2.17B46.69%1.42B66.79%705.85M
Selling expenses -13.91%-101.38M-3.43%-46.45M-24.97%-187.32M-22.94%-132.7M-11.19%-89M-16.61%-44.91M-15.84%-149.89M-12.61%-107.94M-20.08%-80.04M-21.74%-38.51M
Administrative expenses -8.70%-376.62M-3.60%-177.07M-3.01%-662.7M-14.39%-527.54M-7.81%-346.47M-7.54%-170.92M-15.95%-643.32M-18.67%-461.2M-30.28%-321.38M-39.22%-158.95M
Research and development expenses 2.65%-124.69M0.95%-63.91M-11.48%-261.56M-14.20%-195.34M-15.89%-128.08M-13.22%-64.52M-10.76%-234.62M-10.50%-171.06M-18.80%-110.52M-21.33%-56.99M
Profit from asset sales 25,346.07%1.49M32,651.46%1.15M----282.55%45.22K---5.9K41.47%-3.54K----95.63%-24.77K-----20.24%-6.05K
Revaluation surplus -118.58%-98.4M-92.77%12.75M----76.46%710.39M--529.76M40.98%176.41M-----63.97%402.59M-----71.44%125.13M
-Changes in the fair value of other assets -118.58%-98.4M-92.77%12.75M----76.46%710.39M--529.76M40.98%176.41M-----63.97%402.59M-----71.44%125.13M
Impairment and provision -21.18%-36.08M11.22%-18.4M-177.10%-68.1M-0.74%-45.34M-4.81%-29.78M-76.90%-20.73M-0.61%-24.58M-152.89%-45.01M-177.13%-28.41M-105.74%-11.72M
-Other impairment is provision -21.18%-36.08M11.22%-18.4M-177.10%-68.1M-0.74%-45.34M-4.81%-29.78M-76.90%-20.73M-0.61%-24.58M-152.89%-45.01M-177.13%-28.41M-105.74%-11.72M
Special items of operating profit -18.28%88.09M-61.93%11.78M-4.57%863.91M25.78%138.34M-81.95%107.8M-50.70%30.94M-61.84%905.28M-17.65%109.98M-48.26%597.37M79.40%62.75M
Operating profit -55.58%670.96M-44.66%340.28M-5.06%2.5B17.21%2.21B2.38%1.51B-1.46%614.94M-28.70%2.64B-13.08%1.88B-13.47%1.48B-10.08%624.06M
Financing cost -81.71%16.11M37.34%21.92M-44.14%-119.9M-11.06%105.76M383.86%88.09M-47.37%15.96M-233.92%-83.18M-32.28%118.91M-290.77%-31.04M-51.30%30.32M
Share of profits of associates --------164.52%105.18M------------177.13%39.76M----4,817.84%35.56M----
Special items of earning before tax 452.48%3.02M2.21%167.98K-----45.03%2.75M--547.3K-89.86%164.35K----201.12%4.99M----87.04%1.62M
Earning before tax -56.85%690.09M-42.58%362.36M-4.04%2.49B15.38%2.31B8.06%1.6B-3.80%631.06M-29.67%2.59B-14.12%2.01B-12.83%1.48B-13.36%656M
Tax 30.64%-132.51M20.63%-49.79M-7.96%-338.61M-22.61%-286.62M-17.76%-191.06M23.52%-62.74M-7.10%-313.65M-55.66%-233.77M-56.70%-162.24M-137.02%-82.03M
After-tax profit from continuing operations -60.40%557.58M-45.00%312.57M-5.68%2.15B14.42%2.03B6.87%1.41B-0.98%568.33M-32.84%2.28B-18.92%1.77B-17.35%1.32B-20.56%573.97M
Earning after tax -60.40%557.58M-45.00%312.57M-5.68%2.15B14.42%2.03B6.87%1.41B-0.98%568.33M-32.84%2.28B-18.92%1.77B-17.35%1.32B-20.56%573.97M
Minority profit 227.70%64.73M59,975.46%77.5M-52.83%125.08M-11.54%148.24M-84.28%19.75M-100.23%-129.43K-48.76%265.17M-58.59%167.58M-62.42%125.62M-79.20%55.55M
Profit attributable to shareholders -64.50%492.85M-58.65%235.07M0.52%2.03B17.13%1.88B16.47%1.39B9.65%568.46M-29.98%2.02B-9.90%1.6B-5.39%1.19B13.82%518.42M
Basic earnings per share -64.60%0.57-59.09%0.270.43%2.3416.67%2.1716.67%1.6110.00%0.66-29.82%2.33-9.27%1.86-4.83%1.3815.38%0.6
Diluted earnings per share -64.60%0.57-59.09%0.270.43%2.3416.67%2.1716.67%1.6110.00%0.66-29.61%2.33-8.82%1.86-4.17%1.3815.38%0.6
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)IASCAS (2007)CAS (2007)CAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited------Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data